佐勒德罗纳酸,登诺苏马布或特里巴拉提德对2型糖尿病骨微型架构的临时影响:试点试验
Trupti N Prasad1, Rimesh Pal1, Sanjay K Bhadada1
1Department of Endocrinology, Postgraduate Institute of Medical Education and Research, Chandigarh, India-160012.
The Journal of clinical endocrinology and metabolism
|November 3, 2025
概括
特里巴提德改善了2型糖尿病 (T2D) 的绝经后妇女的骨微型架构. 德诺苏马布显示了适度的骨硬度改善,突出了对T2D药理管理进行更大规模研究的需要.
科学领域:
- 内分泌学 在内分泌学.
- 骨生物学 骨生物学 骨生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 2型糖尿病 (T2D) 增加骨折的风险,原因是骨微架构受到损害,即使骨密度正常.
- 有限证据表明有效的药理疗法针对糖尿病骨病.
研究的目的:
- 评估索莱德罗纳酸,登索苏马布和特里巴拉提德对2型糖尿病的绝经后妇女骨微型结构的临时影响.
- 将这些影响与高骨折风险人群的标准护理进行比较.
主要方法:
- 一项为期72周的随机,开放试验试验,涉及129名患有T2D的绝经后妇女.
- 干预措施包括佐莱德罗纳特,代诺苏马布,特里巴拉提德或标准护理 (/胆卡西费醇).
- 使用HR-pQCT评估骨微架构,在24周评估骨周转率标志物.
主要成果:
- 特里巴拉提德显著增强了骨微架构,包括总体和轨道体积骨矿物质密度 (vBMD) 和轨道体数.
- 登诺苏马布改善了椎椎骨的vBMD和数量,椎骨硬度略有增加.
- 佐莱德罗纳特在骨总体vBMD中显示出轻微的改善;骨循环标志物表明了teriparatide的合成代谢窗口.
结论:
- 特里巴拉提德在患有T2D的绝经后妇女的骨微架构中表现出早期的益处.
- 德诺苏马布提供了适度增加的骨硬度.
- 需要进行进一步的大规模研究,以确定糖尿病骨病的最佳治疗策略.
更多相关视频
相关概念视频
Bone Disorders
5.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.0K
Bone Remodeling
40.2K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.2K
Osteoclasts in Bone Remodeling
3.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.9K
Hormones and Bone Tissue
3.7K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.7K


